Radiation Oncology

Medicine & Life Sciences

1. Integrins 100%
2. Radiotherapy 92%
3. Neoplasms 67%
4. Prostate 66%
5. Prostatic Neoplasms 52%
6. Radiation 48%
7. Radiosurgery 42%
8. Cell Line 38%
9. Survival 34%
10. Neoplasm Metastasis 33%
11. Therapeutics 33%
12. Carcinoma 32%
13. efaproxiral 30%
14. Glioblastoma 29%
15. kalinin 29%
16. Brain 28%
17. Laminin 28%
18. Fever 28%
19. Brachytherapy 27%
20. DNA 26%
21. Cell Adhesion 25%
22. Ionizing Radiation 23%
23. Bone Marrow 22%
24. Proteins 21%
25. Head and Neck Neoplasms 20%
26. Matrix Metalloproteinase 7 20%
27. Glioma 20%
28. Pterins 19%
29. Bone and Bones 18%
30. Nicotinamide Phosphoribosyltransferase 17%
31. Cricetulus 16%
32. Phenotype 16%
33. Radioimmunodetection 16%
34. Lung 16%
35. Double-Stranded DNA Breaks 15%
36. Image-Guided Radiotherapy 15%
37. Lymphedema 15%
38. Hot Temperature 15%
39. Melanoma 15%
40. DNA-Activated Protein Kinase 15%
41. Cell Movement 14%
42. Ovary 14%
43. Temperature 13%
44. Recurrence 13%
45. Brain Neoplasms 13%
46. Mitoxantrone 12%
47. Haploidentical Transplantation 12%
48. Non-Small Cell Lung Carcinoma 12%
49. Prostatic Intraepithelial Neoplasia 12%
50. Endorphins 12%
51. Cancellous Bone 12%
52. Alpha Particles 11%
53. Extracellular Matrix 11%
54. Catheters 11%
55. Skin Neoplasms 11%
56. Phosphorylation 11%
57. Laparoscopes 11%
58. Astrocytoma 11%
59. Drug Resistance 10%
60. Doxorubicin 10%
61. Peptides 10%
62. Laminin Receptors 10%
63. Breast Neoplasms 10%
64. DNA Repair 10%
65. Heterografts 10%
66. Growth 9%
67. Paxillin 9%
68. In Vitro Techniques 9%
69. Pharmaceutical Preparations 9%
70. Urokinase-Type Plasminogen Activator 9%
71. Breast 9%
72. Bone Neoplasms 9%
73. Basement Membrane 9%
74. Medulloblastoma 9%
75. Integrin alpha6 9%
76. Skeleton 9%
77. Photons 9%
78. Spinal Cord 9%
79. Keratins 9%
80. Electrons 9%
81. Pteridines 9%
82. DNA Replication 9%
83. Cell Culture Techniques 9%
84. Rodentia 9%
85. Pediatrics 9%
86. S Phase 9%
87. Equine-Assisted Therapy 8%
88. Epithelial Cells 8%
89. Young Adult 8%
90. Multiple Drug Resistance 8%
91. Intensity-Modulated Radiotherapy 8%
92. Drug Therapy 8%
93. Hypoxia 8%
94. Bendamustine Hydrochloride 8%
95. Equipment and Supplies 8%
96. Head 8%
97. MLN 8237 8%
98. Oceans and Seas 8%
99. Colon 8%
100. Radiation Oncology 8%